Cargando…
CDH1 (E-cadherin) Gene Methylation in Human Breast Cancer: Critical Appraisal of a Long and Twisted Story
SIMPLE SUMMARY: Genes can be inactivated by specific modifications of DNA bases, most often by adding a methyl group to the DNA base cytosine if it is followed by guanosine (CG methylation). This modification prevents gene expression and has been reported for many different genes in nearly all types...
Autores principales: | Bücker, Lara, Lehmann, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497067/ https://www.ncbi.nlm.nih.gov/pubmed/36139537 http://dx.doi.org/10.3390/cancers14184377 |
Ejemplares similares
-
Is Upregulation of BCL2 a Determinant of Tumor Development Driven by Inactivation of CDH1/E-Cadherin?
por: Karch, Inga, et al.
Publicado: (2013) -
CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer
por: Caldeira, José Roberto F, et al.
Publicado: (2006) -
Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer
por: Ku, Su-Chi, et al.
Publicado: (2022) -
Worsened outcome in patients with pancreatic ductal carcinoma on long-term diabetes: association with E-cadherin1 (CDH1) promoter methylation
por: Saito, Takeshi, et al.
Publicado: (2017) -
3D Chromatin Architecture Re-Wiring at the CDH3/CDH1 Loci Contributes to E-Cadherin to P-Cadherin Expression Switch in Gastric Cancer
por: São José, Celina, et al.
Publicado: (2023)